These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2379275)

  • 1. Physical and chemical changes of medicinals in mixtures with adsorbents in the solid state. III. Determination of vapor pressure of solid drugs by steam distillation.
    Konno T
    Chem Pharm Bull (Tokyo); 1990 Apr; 38(4):1032-4. PubMed ID: 2379275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical and chemical changes of medicinals in mixtures with adsorbents in the solid state. IV. Study on reduced-pressure mixing for practical use of amorphous mixtures of flufenamic acid.
    Konno T
    Chem Pharm Bull (Tokyo); 1990 Jul; 38(7):2003-7. PubMed ID: 2268904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical and chemical changes of medicinals in mixtures with adsorbents in the solid state. I. Effect of vapor pressure of the medicinals on changes in crystalline properties.
    Konno T; Kinuno K; Kataoka K
    Chem Pharm Bull (Tokyo); 1986 Jan; 34(1):301-7. PubMed ID: 3698136
    [No Abstract]   [Full Text] [Related]  

  • 4. Physical and chemical changes of medicinals in mixtures with adsorbents in the solid state. II. Application of reduced pressure treatment for the improvement of dissolution of flufenamic acid.
    Konno T; Kinuno K
    Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2481-4. PubMed ID: 2605696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryomilling-induced solid dispersion of poor glass forming/poorly water-soluble mefenamic acid with polyvinylpyrrolidone K12.
    Kang N; Lee J; Choi JN; Mao C; Lee EH
    Drug Dev Ind Pharm; 2015 Jun; 41(6):978-88. PubMed ID: 24849785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of binary mixtures of flufenamic, meclofenamic and mefenamic acids by derivative synchronous fluorescence spectrometry.
    Ruiz TP; Lozano CM; Tomás V; Carpena J
    Talanta; 1998 Nov; 47(3):537-45. PubMed ID: 18967356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the physical stability of amorphous drug and drug/polymer melts using variable temperature solid state NMR.
    Forster A; Apperley D; Hempenstall J; Lancaster R; Rades T
    Pharmazie; 2003 Oct; 58(10):761-2. PubMed ID: 14609294
    [No Abstract]   [Full Text] [Related]  

  • 8. [X-ray diffractometry in the analysis of drugs and pharmaceutical forms].
    Bettinetti GP
    Boll Chim Farm; 1989 May; 128(5):149-62. PubMed ID: 2690894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative study of solid-state acid-base reactions between polymorphs of flufenamic acid and magnesium oxide using X-ray powder diffraction.
    Chen X; Stowell JG; Morris KR; Byrn SR
    J Pharm Biomed Anal; 2010 Mar; 51(4):866-74. PubMed ID: 19906502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating vapor pressure curves by thermogravimetry: a rapid and convenient method for characterization of pharmaceuticals.
    Chatterjee K; Hazra A; Dollimore D; Alexander KS
    Eur J Pharm Biopharm; 2002 Sep; 54(2):171-80. PubMed ID: 12191689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stabilization of metastable flufenamic acid by inclusion of mefenamic acid: solid solution or epilayer?
    Lee EH; Byrn SR
    J Pharm Sci; 2010 Sep; 99(9):4013-22. PubMed ID: 20589947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of alkaloid-containing drugs by thin-layer chromatography after micro steam distillation.
    Jolliffe GH; Shellard EJ
    J Chromatogr; 1970 Apr; 48(1):125-31. PubMed ID: 5459020
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent advances in the characterization of amorphous pharmaceuticals by X-ray diffractometry.
    Thakral S; Terban MW; Thakral NK; Suryanarayanan R
    Adv Drug Deliv Rev; 2016 May; 100():183-93. PubMed ID: 26712710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of gabapentin polymorphs in gabapentin/excipient mixtures using solid state
    Tinmanee R; Larsen SC; Morris KR; Kirsch LE
    J Pharm Biomed Anal; 2017 Nov; 146():29-36. PubMed ID: 28843174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additive-induced metastable single crystal of mefenamic acid.
    Lee EH; Byrn SR; Carvajal MT
    Pharm Res; 2006 Oct; 23(10):2375-80. PubMed ID: 16927183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The significance of polymorphism in the analysis of drugs].
    Hoeke M
    Pharm Weekbl; 1969 Aug; 104(31):935-51. PubMed ID: 5345445
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of solid state properties of solid dispersions prepared by hot-melt extrusion and solvent co-precipitation.
    Dong Z; Chatterji A; Sandhu H; Choi DS; Chokshi H; Shah N
    Int J Pharm; 2008 May; 355(1-2):141-9. PubMed ID: 18243605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raman spectroscopy for the in-line polymer-drug quantification and solid state characterization during a pharmaceutical hot-melt extrusion process.
    Saerens L; Dierickx L; Lenain B; Vervaet C; Remon JP; De Beer T
    Eur J Pharm Biopharm; 2011 Jan; 77(1):158-63. PubMed ID: 20933084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissolution improvement of four poorly water soluble drugs by cogrinding with commonly used excipients.
    Vogt M; Kunath K; Dressman JB
    Eur J Pharm Biopharm; 2008 Feb; 68(2):330-7. PubMed ID: 17574401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acids as co-amorphous excipients for simvastatin and glibenclamide: physical properties and stability.
    Laitinen R; Löbmann K; Grohganz H; Strachan C; Rades T
    Mol Pharm; 2014 Jul; 11(7):2381-9. PubMed ID: 24852326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.